Epiminder, an Australian biotech firm, has successfully implanted its first scalp implant in a patient in the United States.

Australian gold equities experienced a robust December quarter in the 2026 fiscal year, according to RBC Capital Markets ...

Cryptocurrencies experienced a sharp decline as risk assets faltered and demand for safe-haven assets increased. This market ...

Tech-recruitment company Hiremii has announced a $1.8m placement from sophisticated and professional strategic investors, a ...

China's economy expanded at an annual pace of 5 per cent in 2025, according to official government data. The growth was ...

RBC Capital Markets analyst Craig Wong-Pan has warned that Australian-listed healthcare companies are likely to face a ...

Despite a series of policy shocks and unconventional actions by US President Donald Trump, markets have largely remained ...

Airlie Funds Management is banking on a resurgence in technology stocks and resilient iron ore markets as its flagship $1 ...

Catalyst Metals emerged as the top performer on the ASX 200 Monday following the announcement of a significant high-grade ...

Gold and silver prices have surged to record highs as escalating tensions between the US and Europe fuel concerns over a ...

Strategic Energy Resources Limited (SER), an ASX-listed company focused on discovering world-class copper deposits in ...

By Dr Shane Oliver, Chief Economist and Head of Investment Strategy at AMP. Key points 2025 was another strong year for ...